RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkae043 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Carolina Galan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Genentech, Inc, South San Francisco, CA, United States. Hauptthemen laut MEDLINE: Th17 Cells, Cell Differentiation, Epigenesis, Genetic, Histones. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
A gene encoding the transcription factor RTF1 has been associated with an increased risk of ulcerative colitis (UC). In this study, we investigated its function in modulating T cells expressing interleukin-17A (Th17 cells), a cardinal cell type promoting intestinal inflammation. Our results indicate that Rtf1 deficiency disrupts the differentiation of Th17 cells, while leaving regulatory T cells (Treg) unaffected. Mechanistically, RTF1 facilitates histone H2B monoubiquitination (H2Bub1), which requires its histone modification domain (HMD), for supporting Th17 cell function. Impaired Th17 differentiation was also observed in cells lacking the H2Bub1 E3 ligase subunit RNF40, an enzyme known to physically interact with RTF1. Thus, our study underscores the essential role of RTF1 in H2Bub1-mediated epigenetic regulation of Th17 cell differentiation. Understanding this process will likely provide valuable insights into addressing Th17-associated inflammatory disorders. (Images were created with BioRender).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genentech, Inc, South San Francisco, CA, United States.
- Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
- Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
- Bio2Q, Keio University, Tokyo, Japan.
ORCID-Profile: Carolina Galan, Guangqing Lu, Yifang Liu
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Galan, C., Lu, G., Gill, R., Li, D., Liu, Y., Huh, J. R., & Hang, S. (2025). RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkae043
Vancouver
Galan C, Lu G, Gill R, Li D, Liu Y, Huh JR, et al. RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkae043
BibTeX
@article{Galan2025,
author = {Galan, Carolina and Lu, Guangqing and Gill, Richard and Li, Dun and Liu, Yifang and Huh, Jun R and Hang, Saiyu},
title = {RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkae043}
}
EUVIMED